Cereton solution 250mg / ml, 4ml No. 5
Expiration Date: 05/2027
Russian Pharmacy name:
Церетон раствор 250мг/мл, 4мл №5
acute (solution for intravenous and intramuscular injection) and recovery periods of severe TBI and ischemic stroke, recovery period of hemorrhagic stroke, occurring with focal hemispheric symptoms or symptoms of brain stem damage;
psychoorganic syndrome against the background of degenerative and involutional brain changes;
cognitive disorders (impaired mental function, memory, confusion, disorientation, decreased motivation, initiative and ability to concentrate), incl. with dementia and encephalopathy;
senile pseudomelancholia.
Solution for i / v and i / m administration
V / v, v / m. In acute conditions, it is administered intravenously (slowly) or deeply intramuscularly (slowly) at 1000 mg / day (1 amp.) For 10-15 days.
Capsules
Inside. In the recovery period of TBI, ischemic or hemorrhagic stroke, CeretonЃ is prescribed 800 mg in the morning and 400 mg in the afternoon for 6 months.
In chronic cerebrovascular insufficiency and dementia syndromes - 400 mg (1 capsule) 3 times a day, preferably after meals, for 3-6 months.
| Solution for intravenous and intramuscular administration | 1 amp. (4 ml) |
| active substance: | |
| choline alfoscerate polyhydrate (in terms of anhydrous choline alfoscerate) | 1000 mg |
| excipients: water for injection - up to 4 ml |
| Capsules | 1 caps. |
| active substance: | |
| choline alfoscerate (in terms of 100% substance) | 400 mg |
| excipients: glycerol - 50 mg; purified water - up to 590 mg | |
| capsule: gelatin; sorbitol; glycerol; methyl parahydroxybenzoate; propyl parahydroxybenzoate; titanium dioxide; iron dye yellow oxide; purified water |
hypersensitivity to the drug or its components;
acute stage of hemorrhagic stroke;
pregnancy;
breastfeeding period;
age up to 18 years (due to lack of data).